Live Breaking News & Updates on Metastatic crc

HER2-Amplified Colorectal Cancer: Clinical Trial Data

A focused discussion on HER2-amplified colorectal cancer and respective clinical trials that inform use of targeted agents in this setting.

Positive-colorectal-cancer , Novel-approaches , Amplified-colorectal-cancer , Clinical-trial-data , Colorectal-cancer , Metastatic-crc , Colon-cancer , Rectal-cancer , Ther2 , Her2-positive , Tucatinib

Colorectal Cancer: Prevalence, Workup, and Molecular Subtypes

Opening their discussion on colorectal cancer, expert panelists consider its growing prevalence and highlight key molecular subtypes.

Positive-colorectal-cancer , Novel-approaches , Colorectal-cancer , Metastatic-crc , Colon-cancer , Rectal-cancer , Ther2 , Her2-positive , Biomarker-testing , Molecular-testing , Molecular-lab-test

Colorectal Cancer: An Overview on Molecular Profiling

Shared insight on appropriate molecular lab testing options that should be explored following a diagnosis of colorectal cancer.

Positive-colorectal-cancer , Novel-approaches , Molecular-profiling , Colorectal-cancer , Metastatic-crc , Colon-cancer , Rectal-cancer , Ther2 , Her2-positive , Biomarker-testing , Molecular-testing

Metastatic Colorectal Cancer: Future Directions in Care

Expert panelists identify key takeaways and share their excitement for future directions in the management of metastatic colorectal cancer.

Metastatic-colorectal-cancer-with , Positive-disease , Colorectal-cancer , Future-directions , Crc , Metastatic-crc , Dmcrc , Ngs , Next-generation-sequencing , Molecular-testing , Biomarker-testing

Novel Combination Strategies in mCRC: The STELLAR-303 and SUNLIGHT Trials

Before closing out their review of combination therapy in metastatic colorectal cancer, panelists discuss the STELLAR-303 and SUNLIGHT clinical trials.

Metastatic-colorectal-cancer-with , Positive-disease , Combination-strategies , Colorectal-cancer , Crc , Metastatic-crc , Dmcrc , Immunotherapy , Immune-checkpoint-inhibitors , Tki-therapy , Tyrosine-kinase-inhibitors

Combination IO/TKI Strategies in Metastatic Colorectal Cancer

A comprehensive review on combination strategies with immune checkpoint and tyrosine kinase inhibitors in patients with metastatic colorectal cancer.

Metastatic-colorectal-cancer-with , Positive-disease , Metastatic-colorectal-cancer , Colorectal-cancer , Crc , Metastatic-crc , Dmcrc , Immunotherapy , Immune-checkpoint-inhibitors , Tki-therapy , Tyrosine-kinase-inhibitors